Bioresorbable Polymers Market Size, Share, Growth, Industry Analysis, By Type (Polylactic Acid, Polyglycolic Acid, Polysaccharides, Polycaprolactone PLGA and Others), By Application (Drug Delivery and Orthopedics) and regional forecast to 2033.

BIORESORBABLE POLYMERS MARKET OVERVIEW

The global Bioresorbable Polymers Market size was valued at 1.023 billion USD in 2025 and with the rising demand the market is expected to reach an estimated value of 1.718 billion USD by 2033, reflecting a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.

These polymers are known to degrade inside the body with time or these polymers are absorbed safely by the body without the need for any surgical procedures. This property of the polymer makes it ideal for use in the healthcare industry and as a result it is widely used in drug delivery, tissue engineering and also in medical implants. Due to these applications in the medical industry, the market for bioresorbable polymers has rapidly increased in recent years and has ultimately led to the growth of the market on a global scale.

KEY FINDINGS

• Market Size and Growth: The global Bioresorbable Polymers Market size was valued at 1.023 billion USD in 2025 and with the rising demand the market is expected to reach an estimated value of 1.718 billion USD by 2033, reflecting a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.

• Key Market Trends: Around 30% of global usage of bioresorbable polymers is now concentrated in orthopedic implants, driven by patient preference for non-permanent solutions.

• Key Market Drivers: Over 60% of surgeons prefer bioresorbable materials to eliminate the need for secondary surgeries, supporting faster patient recovery and reduced healthcare costs.

• Technological Advancements: Advanced polymer blends now offer up to 90% precision in controlling degradation rates, enabling application-specific customization in bioresorbable products.

• Regional Growth: North America accounts for nearly 40% of market share, supported by innovation hubs and increasing adoption of biodegradable solutions in clinical procedures.

• Type Segmentation: Polylactic acid (PLA) and poly(lactic-co-glycolic acid) (PLGA) make up more than 50% of total product usage due to their high biocompatibility and performance.

• Application Segmentation: Orthopedic applications dominate with over 65% market demand, followed by drug delivery systems and dental applications utilizing bioresorbable formats.

• Key Players: Leading companies contribute to around 45% of global supply, focusing heavily on R&D, precision engineering, and expanding their bioresorbable product portfolios.

GLOBAL CRISIS IMPACTING THE MARKET

"US TARIFF IMPACT"

Tariffs when imposed on the bioresorbable polymers market could ultimately lead to an increase in the cost of the imported bioresorbable polymers which in turn will increase the medical devices made by these polymers. This will result in a large portion of the global population to opt away from this medical procedure and this might cause a gradual decline in the global bioresorbable polymers market in the long run.

Tariffs are also known to disrupt the smooth supply of the raw materials and end product to the users leading to a shortage or decline in the availability of the product to the users. This will lead to manufacturers shifting towards domestic suppliers in order to mitigate the cost. From this it can be inferred that tariff has a negative impact on the global bioresorbable polymers market.

LATEST TRENDS

"Growth in Orthopedics Industry is the Latest Trend in the Market"

As these polymers are known to be absorbed by the body without any side effects over time, it has found its primary application in the orthopedic sector of the healthcare industry. In the orthopedic sector these polymers are used for making pins, screws and plates which are used for fixing the fractured bones and in the bone regeneration process. These applications have greatly helped with the growth of the bioresorbable polymers in recent years and has become the latest trend in the market.

BIORESORBABLE POLYMERS MARKET

BY TYPE

Based on Type, the global bioresorbable polymers market is segmented into Polylactic Acid, Polyglycolic Acid, Polysaccharides, Polycaprolactone, PLGA and Others.

• Polylactic Acid: This type of polymer breaks down into lactic acid, a naturally occurring component over time and as a result reduces the long term complication and they are known to be non-toxic and biocompatible. These polymers are also obtained from renewable sources such as corn starch or sugarcane. Due to these features they are used as bone screws, tissue scaffolds, for controlled and targeted drug delivery and also in tissue regeneration. These applications have resulted in the growth of the polylactic acid and its market is estimated to reach an estimated value of 4.41 billion USD by 2032.

• Polyglycolic Acid: Polyglycolic acid or the PGA for short, breaks down just like the polylactic acid into a naturally occurring component called the glycolic acid. The PGA is known to dissolve quickly as within months and they are stiff and have high strength making it ideal for medical applications. The key driving factors of the PGA market is its use in the orthopedic sector in health care where they are used as sutures and drug delivery. The key application is the scaffolding for various tissue engineering applications. These factors have greatly helped in the growth of the PGA market and as a result its value is expected to reach an estimation of 11.79 billion USD by 2032.

• Polysaccharides: These are a class of biopolymers that are composed of sugar molecules. They are used in the health care industry mainly due to their biocompatible and biodegradable properties. These polymers are also obtained from renewable sources such as planets and microorganisms. These polysaccharides when incorporated into nanoparticles, hydrogels and scaffolds can be used for a diverse range of medical applications some of which include drug delivery, healing of the wounds and also in tissue engineering. These applications played a crucial role in the growth of the polysaccharides market within the bioresorbable polymers industry.

• Polycaprolactone: Also known as PCL for short, this polymer is known for degrading slowly and it takes nearly 2 to 4 years for complete degradation. PLC are flexible and have elastic properties. This property has made it suitable for medical applications such as drug delivery, tissue engineering and medical implants. Since the degradation takes a longer time, the PCL helps with long term tissue support as well. As a result, the market for PCL is projected to reach 1.39 billion USD by 2032.

• PLGA: PLGA which is also referred to as Poly (latic-co-glycolic acid) is a copolymer of PLA and PGA. These polymers are biodegradable and non-toxic. Their degradation rate can be controlled by adjusting the ratio of PLA and PLG. These properties have resulted in the PLGA being constantly used in the medical field, such as drug delivery, tissue engineering and medical implants such as bone grafting and sutures. The polymers can be customized to fit the users’ needs and specific applications. As a result, the market for PLGA in the healthcare industry is valued at 6.33.97 billion USD by the year 2034.

• Others: Polydioxanone, also a biodegradable polymer, is extensively used in the medical industry such as sutures, bone recovery and even in tissue engineering as well. Polyanhydrides are particularly known for surface erosion. These properties are some of the key factors for the market growth in bioresorbable polymers market.

BY APPLICATION

Based on Application, the global bioresorbable polymers market is segmented into Drug Delivery and Orthopedics.

• Drug delivery: Due to the bio-compactable and biodegradable properties these polymers are employed in a wide range of medical applications such as drug delivery especially for the orthopedic industry of healthcare. These polymers can break down into nontoxic components over time which increases the therapeutic efficiency and also helps with reducing the dosing frequency. In recent years they are also used for delivery drugs in the dental industry as well. These diverse applications have helped with the growth of the bioresorbable polymers market with the drug delivery sector.

• Orthopedics: The primary application of the bioresorbable polymers is in the orthopedics industry. In which they are used in fixing the bones by creating implants with these polymers and these polymers gradually degrade as the bone heals. It is used in scaffolding for tissue growth and regeneration and also used in targeted drug delivery. The use of these polymers in orthopedics is a promising area for research as it offers potential benefits for the patients and also results in improved treatment outcomes as well. Hence the market for bioresorbable polymers within the orthopedics was valued at 1.62 billion USD in 2024 and with the rising demand its market is expected to reach 3.77 billion USD by 2033.

MARKET DYNAMICS

Market dynamics includes driving and restraining factor, opportunities and challenges stating the market conditions.

DRIVING FACTORS

"Advancement in Medical Technology is Driving the Market Growth"

As the healthcare industry develops, it helps both the patient and healthcare providers get access to high-quality healthcare devices and with the growing need for biodegradable and non-toxic surgical procedures results in not only the use of the bioresorbable polymers but also leads to new research and innovations to upgrade the orthopedic treatment procedures. This has played a vital role in the growth of the bioresorbable polymers market on the global scale.

"Biodegradability Factor is Fueling the Market Growth"

The bioresorbable polymers are known to degrade with time especially when used in orthopedics surgeries for the patient and it leaves no toxic traces in the patient body. This has attracted not only the orthopedic surgeon and researchers but also the government, who promote biodegradable solutions and eco-friendly medical practices. Hence biodegradable property is a key factor in the growth of the bioresorbable polymers market.

RESTRAINING FACTORS

"High Cost Factor is Restraining the Market Growth"

" "The cost of manufacturing the bioresorbable polymers medical devices is quite high as it requires specialized manufacturing procedures and rigorous quality control continuously. The surgical procedures involving the bioresorbable polymers devices also require highly skilled laborers. This results in the increase in cost of not only manufacturing but also the surgical process as well. This can become a restraining factor that can ultimately lead to decline in the Bioresorbable Polymers Market growth in coming years.

CHALLENGE

"Limited Awareness is Challenging the Market Growth"

The bioresorbable polymers is a new and upcoming industry with research being carried out continuously to come up with new and innovative procedures and services. As a result, not many know about these polymers and their uses especially in urban and rural areas. This limited awareness among the common population can be quite challenging for the growth of the bioresorbable polymers market on the global scale and it is also resulting in the limited research in this field which greatly affects the overall growth of the bioresorbable polymers market

OPPORTUNITY

"Use as Orthopedic Devices is Opening New Opportunities for the Market Growth"

The bioresorbable polymers can be made into orthopedic devices such as screws, plates and pins. This fact acts as a significant market driver for polymer market growth. It should be also noted that these polymers are also biodegradable and as such eliminates a second surgery for the removal of the devices inside the patient. This has greatly helped by opening new opportunities for the growth of the bioresorbable polymers and as a result its market was valued at 4.19 billion USD in 2024 and due to these applications its market is expected to reach 9.18 billion USD by 2032.

BIORESORBABLE POLYMERS MARKET REGIONAL INSIGHT

• NORTH AMERICA (US)

The United States bioresorbable polymers market holds a significant position in the global platform. The market in this region is driven by factors such as advancement in the healthcare industry, increasing demand for minimal invasive surgeries and the rising awareness about the biodegradable surgical procedures. As a result, the market in the US region was valued at 1.30 billion USD in the year 2022 and with the rising demand the market is expected to reach an estimated value of 3.67 billion USD by 2030. The North America region holds nearly 40% of the global bioresorbable polymers market share.

• EUROPE

The Europe bioresorbable polymers market is a steadily growing market. The reason for the growth of the bioresorbable polymers in this region is mainly due to the demand for bioresorbable polymers in the medical applications, the government initiatives for a less toxic and biodegradable surgical procedures and the growing old population. Hence the market in the Europe region was valued at 0.34059 billion USD in the year 2021 and with rising demand the market is expected to grow with a CAGR of 11.9% during the forecast period. Europe is considered to have the second largest biodegradable polymers in the world.

• ASIA

The Asia-Pacific is experiencing a rapid growth in the bioresorbable polymers market. The growth in this region is fueled by increasing biodegradable surgical procedures, government initiatives for a less toxic and biodegradable medical care and the rapidly developing healthcare industry in this region. The market for the bioresorbable polymers market in this region is expected to reach an estimated value of 1.697 billion USD by 2028, With countries such as China, India and South Korea being the key industry players in this region.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market Through Innovation and Market Expansion"

The key industry players are also termed as the dominant players in the global bioresorbable polymers market. They are responsible for keeping up with the latest trends in the global bioresorbable polymers market that resulted in the boost of market growth. Key players invest continuously in the research and development to come up with new and innovative procedures and services to fuel the market growth. Key players are responsible for the smooth supply and distribution of the raw materials and end product to the users. Key industry players come up with new strategies continuously to promote the market in times of decline or stagnation.

LIST OF KEY BIORESORBABLE POLYMERS COMPANIES

• Corbion (Netherlands)
• Evonik Industries (Germany)
• Foster Corporation (U.S.)
• KLS Martin (Germany)
• Poly-Med (India),
• LACTEL Absorbable Polymers (U.S.)
• DSM (Netherlands)
• MAST Biosurgery (U.S.)
• Zeus (U.S.)
• Arctic Biomaterials (Finland)

KEY INDUSTRY DEVELOPMENT

August 2024: Ashland completed its second expansion of its pharmaceutical injectable manufacturing and R&D lab in Ireland. This expansion was mainly done to meet the rising demand for innovative bioresorbable polymers chemistry. This expansion is greatly supported by the Irish government as well.

REPORT COVERAGE

This report covers the basis of the bioresorbable polymers and its market on the global scale. The report also covers the latest trends in the market that resulted in the boost of sales. It also briefly covers the impact of tariff on the global bioresorbable polymers market as well.

The report explains the segmentation of the bioresorbable polymers market on the basis of type and applications and its contribution to the market growth. The role of both driving factors and opportunities in the market growth and the impact of restraining factors and challenges in the hindrance of the growth.

The report describes the regional insight of the global bioresorbable polymers market. The role of key industry players in the market growth and the key industry development that took place recently in the market.